Catalyst Launches Patent Suits Over Drug Firdapse
Florida-based Catalyst Pharmaceuticals Inc. has launched a series of patent infringement suits in federal courts against pharmaceutical companies relating to a drug that treats a rare autoimmune disease....To view the full article, register now.
Already a subscriber? Click here to view full article